FDA – Page 3 – medicarereport.org

Sunday, May 4, 2025

Latest:

FDA Health Care Finance Health Insurance Medicare - General Part D/Prescription Drugs

Eileen Cook June 28, 2024June 28, 2024 FDA, Formularies, Health Insurers, Healthcare Costs, medicare, Medicare Part D, PBM

Health insurers cover fewer drugs and make them harder to get

(By Sydney Lupkin for NPR) Insurance coverage isn’t what it used to be when it comes to prescription drugs. Insurance

Aging Alzheimer's/Dementia FDA Part D/Prescription Drugs Women's Health

Eileen Cook June 18, 2024June 18, 2024 FDA, Older Adults, Older Women, Prescription Drugs, Women's Health Research, Women's Health

Older Women Are Different Than Older Men. Their Health Is Woefully Understudied.

(By Judith Graham for KFF Health News) Medical research has shortchanged women for decades. This is particularly true of older

FDA Medical Technology

Eileen Cook June 14, 2024 FDA, Medical devices, Natural Disaster Contingency Plan, NOAA, Supply Chain Disruptions

FDA to healthcare supply chain: Prepare for hurricanes

(By Paige Twenter for Becker’s Hospital Review) During the current hurricane season, healthcare providers should brace for supply chain disruptions,

Alzheimer's/Dementia FDA Part D/Prescription Drugs

Eileen Cook June 11, 2024June 11, 2024 Alzheimer's Treatment, Donanemab, FDA, Healthcare Costs, Medicare Part D, Older Adults

FDA advisors strongly back new Alzheimer’s drug, despite risks and limitations

(By Jon Hamilton for NPR) Advisors to the Food and Drug Administration have recommended unanimously that the agency approve the

FDA Part D/Prescription Drugs PTSD

Eileen Cook May 14, 2024May 14, 2024 Ecstasy, FDA, PTSD

As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence

(By Will Stone for NPR) In a matter of months, the Food and Drug Administration is expected to decide whether

FDA Health Care Finance Legal Actions/Court Decisions Medical Technology

Eileen Cook April 30, 2024April 30, 2024 CPAP settlement, FDA, Healthcare Finance, Legal Actions

What consumers should know as Philips agrees to $1.1 billion CPAP settlement

(By Bill Chappell for NPR) Millions of CPAP sleep apnea machines made by the medical device maker Philips and a

CMS Medicare - General Part D/Prescription Drugs

Eileen Cook April 29, 2024April 29, 2024 CMS, FDA, medicare, Medicare Part D, Older Adults, Reduce Heart Risk, Semaglutide, Wegovy

An Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk

(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6

Aging CMS FDA Medicare - General Medicare Advantage Part D/Prescription Drugs

Eileen Cook April 24, 2024April 24, 2024 CMS, FDA, Healthcare Costs, medicare, Medicare Advantage, Medicare Part D, Obesity, Older Adults, Ozempic, Wegovy

A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity

(By Juliette Cubanski, Tricia Neuman, Nolan Sroczynski, and Anthony Damico for The Kaiser Family Foundation Published: Apr 24, 2024) The

Eileen Cook March 25, 2024March 25, 2024 Biotech Invivyd, COVID-19, FDA, Immune compromised, Pemgarda

FDA authorizes new drug to protect immune compromised from Covid-19

(By Jason Mast for STAT) The Food and Drug Administration on Friday authorized a new antibody to protect immunocompromised individuals

Aging CDC Emerging Health Issues FDA Health Care - General

Eileen Cook March 1, 2024March 1, 2024 CDC, FDA, Guillain-Barre syndrome, Older Adults, RSV Vaccine

RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest

(By Helen Branswell for STAT) The new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be